<DOC>
	<DOCNO>NCT02132247</DOCNO>
	<brief_summary>The primary purpose study determine whether Flector Patch safe use child . The secondary purpose ass blood level diclofenac , active ingredient Flector Patch .</brief_summary>
	<brief_title>Safety Study Flector Patch Children With Minor Soft Tissue Injuries</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Soft Tissue Injuries</mesh_term>
	<mesh_term>Athletic Injuries</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Diclofenac hydroxyethylpyrrolidine</mesh_term>
	<criteria>Age 6 16 year , either gender Informed consent : 69 year old must parent/legally authorize representative complete Parental Permission Form ; 1016 year old must complete Children 's Assent Form parent/legally authorize representative complete Parental Permission Form Minor soft tissue injury within 96 hour study entry Spontaneous pain least moderate intensity ( i.e . pain least 3 6point Wong Baker Faces scale pain severity assessment patient ) Injury must consider Investigator clinically significant Negative urine pregnancy test screen female subject childbearing potential ( start menstrual cycle ) Able read speak English Available parent immediate two week period follow study enrollment Major soft tissue injury ( Fractures exclusionary injury stabilize device , e.g . hard cast , remove allow patch apply site injury ) Open skin lesion dermatological condition ( e.g . skin infection , eczema ) within injured area Injury midline involve spine , digits hand Prior injury site within past 3 month Three prior injury ( minor major ) region past Injury occur 96 hour prior study entry Prior use topical medication involve area within 48 hour study entry Allergic disorder , include asthma urticaria , associate exposure aspirin NSAID Coagulation defect Prior use overthecounter ( OTC ) analgesic shortacting nonsteroidal antiinflammatory drug ( NSAIDs [ ibuprofen , ketoprofen ] ) within 6 hour study entry ( acetaminophen permit time study entry ) Prior use narcotic analgesic within 7 day study entry Prior use systemic antiinflammatory steroidal drug within 60 day study entry Prior use longacting NSAIDs piroxicam naproxen since injury Concomitant use drug may susceptible interaction diclofenac , affect safety use concomitantly ( serotoninselective reuptake inhibitor ( SSRI ) , lithium , digoxin , anticoagulant , antidiabetic agent , cyclosporin , methotrexate , quinolone antimicrobial , NSAIDs , steroid diuretic ) Subjects suffer psychiatric disorder ( include depression ) Handicapped patient , handicap prevents either assess pain safely use patch ( e.g. , pervasive developmental disorder autism , Asperger syndrome , Rett syndrome , Heller 's syndrome , severe attention deficit hyperactivity disorder ( ADHD ) , severe mental retardation traumatic , congenital origin ) History current alcohol drug abuse date &lt; 1 year Severe cardiac , renal hepatic impairment Severe systemic disease ( e.g . cancer , severe acute infection ) Any underlying disease medication severely compromise patient 's immune system Prior history chronic pain disorder Prior history GI bleeds/ulcers , liver kidney disease Hypersensitivity diclofenac NSAID drug ( include aspirin ) Females pregnant breast feeding Patients participate involved clinical investigation three month precede entry study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Minor athletic injury</keyword>
	<keyword>Pain</keyword>
	<keyword>Diclofenac</keyword>
	<keyword>Topical</keyword>
</DOC>